Survival in strong, reduced, and negative immunohistochemical expression of CD20. (A) PFS of patients with either strong, reduced, or negative immunohistochemical expression of CD20 antigen. (B) OS of patients with either strong, reduced, or negative immunohistochemical expression of CD20 antigen.